Two-Thirds of Next-Gen Sequencers in Database of Worldwide Facilities Come From Illumina
March 23, 2010
Two-Thirds of Next-Gen Sequencers in Database of Worldwide Facilities Come From Illumina
Illumina's sequencers account for almost two thirds, and 454's and Applied Biosystems' each for more than 15 percent of about 750 next-gen sequencing instruments listed in a user-maintained database of next-gen sequencing facilities around the world.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Products
July 19, 2011 / In Sequence - In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
October 2, 2012 / In Sequence - TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News - In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - SeqWright Purchases a Second HiSeq, Scales up Bioinformatics Capabilities
January 11, 2011 / In Sequence